...
首页> 外文期刊>Archives of pharmacal research >Inhibitory effects of SKI3246, the rhizome extract of Atractylodes japonica, on visceral hypersensitivity in experimental irritable bowel syndrome rat models
【24h】

Inhibitory effects of SKI3246, the rhizome extract of Atractylodes japonica, on visceral hypersensitivity in experimental irritable bowel syndrome rat models

机译:白术的根茎提取物SKI3246对肠易激综合征大鼠模型内脏超敏的抑制作用

获取原文
获取原文并翻译 | 示例
           

摘要

We evaluated the effect of SKI3246, the 50 % ethanol extract of the rhizome of Atractylodes japonica, on visceral hypersensitivity, which is a major characteristic feature of IBS. We used various rat models of visceral hypersensitivity to assess the visceral pain responses to colorectal distension (CRD) in comparison with conventional IBS treatments. Oral administration of SKI3246 dose-dependently and significantly attenuated the abdominal withdrawal reflex (AWR) score in a model of acetic acid-induced visceral hypersensitivity. We also found that it reduced the number of abdominal contractions in response to CRD in a model of 2,4,6-trinitrobenzenesulfonic acid-induced visceral hypersensitivity, which was comparable to ramosetron or alosetron. Furthermore, treatment with SKI3246 also increased the pain threshold and abolished the elevated AWR scores to CRD in a rat model of neonatal maternal separation. We presumed that the modulation of the NK2 receptor is involved in the inhibitory activity of SKI3246 on the basis that it significantly inhibited the contraction of the distal colonic muscle induced by neurokinin A, the NK2 receptor agonist. The present results indicate that SKI3246 has the potential to be an effective therapeutic agent for IBS, especially insofar as it can relieve visceral hypersensitivity.
机译:我们评估了白术根茎的50%乙醇提取物SKI3246对内脏超敏反应的影响,这是IBS的主要特征。与传统的IBS治疗相比,我们使用了多种内脏超敏性大鼠模型来评估内脏对结肠直肠扩张(CRD)的疼痛反应。在乙酸引起的内脏超敏性模型中,口服SKI3246剂量依赖性并显着降低了腹部缩回反射(AWR)评分。我们还发现,在2,4,6-三硝基苯磺酸引起的内脏超敏性模型中,它减少了对CRD的腹部收缩次数,这与雷莫司琼或阿洛司琼相当。此外,在新生儿母体分离的大鼠模型中,使用SKI3246的治疗还增加了疼痛阈值,并消除了CRD的AWR评分升高。我们推测NK2受体的调节与SKI3246的抑制活性有关,因为它显着抑制了由NK2受体激动剂神经激肽A诱导的远端结肠肌肉的收缩。目前的结果表明,SKI3246具有成为IBS的有效治疗剂的潜力,特别是在其可以减轻内脏超敏性方面。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号